ThermoGenesis Corp. designs, develops and markets automated and semi-automated devices and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells, wound healing proteins or growth factors from a single unit of cord blood or the patient’s own blood in less than one hour. Initially, the Company developed medical devices for ultra rapid freezing and thawing of blood components, which the Company manufactures and distributes to blood banks and hospitals. The Company’s business model is based on the sale of medical devices and the recurring revenues generated from the companion single-use, sterile disposable products. Its products are sold in 34 countries throughout the world. The Company’s end user customers include private and public cord blood banks, surgeons, hospitals and research institutions.